Targeting S1P signaling by SPHK2 dysfunction significantly suppressed cancer development in the mouse model of colitis-associated cancer [58], whereas SPHK1 inhibition reduced peritumoral lymphatic density and LN metastases [20]. Here, MBTPS1 is linked to cancer.